Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* women scheduled for elective gynecological surgery under combined spinal-epidural anesthesia~Exclusion Criteria:~* contraindications for CSE placement~* known allergy, sensitivity, or contraindication to opioid and nonopioid analgesic drugs~* history of bleeding disorders, peptic ulceration, or anticoagulant use within the past month~* current pregnancy or breastfeeding~* history of known or suspected drug abuse~* unable to understand the use of pain assessment scales and the PCA device~* Patient with asthma or bronchospasm, requiring treatment with glucocorticoids~* poorly controlled hypertension or diabetes, a chronic or acute renal or hepatic disorder, or inflammatory bowel disease~* patients had taken antidepressants, narcotic analgesics, antihistamines, anxiolytics, hypnotics, sedatives, NSAIDs, or corticosteroids up to 24 h before receipt of the study medication

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Normal Saline (Type: PLACEBO_COMPARATOR): Before incision, patients in controlled Group received NS
- parecoxib sodium (Type: EXPERIMENTAL): Before incision, parecoxib patients received 40mg of parecoxib IV

Based on this trial design, predict the completion outcome and termination type (if applicable).